We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Partnership To Provide Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain

Product News   Jul 08, 2020

 
New Partnership To Provide Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain

Credit: rawpixel

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Evotec Biologics to Produce Monoclonal Antibody Products Against COVID-19 for the DOD

Product News

Evotec SE has announced that the U.S. Department of Defense has awarded its Seattle-based subsidiary, Just – Evotec Biologics, Inc. a contract valued up to $18.2M to develop and manufacture monoclonal antibodies (mAbs) for treatment and/or prevention of COVID-19.

READ MORE

Sphere Fluidics and Heriot-Watt University Partner To Develop Next Generation Droplet Generator Instrumentation

Product News

Sphere Fluidics and Heriot-Watt University have been awarded a grant from Innovate UK to facilitate the development of novel droplet generator instrumentation.

READ MORE

Sinovac COVID-19 Vaccine Collaboration Receives Approval for Phase III Trial

Product News

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced an update to its previously announced partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE